Applications Published 22 November 2000
Published: 25-Jun-2001
aThe following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
aThe following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Transmucolsal formulations of levosimendan
Orion 1052972*Compsns containing organic compounds
Novartis 1052974*Propofol compsn containing sulphite
Sicor 1052975*Method for ultrasound triggered drug delivery
Point Biomedical Corp 1052976*Treatment of chronic inflammatory disorders of the gastrointestinal tract
Bolonick, Joel; Stewart, Alan 1052977*Encapsulation system with organic core and mineral cortex based on aluminium hydroxxycarbonate and preparation method
Rhodia Chimie 1052978*Device for releasing substances
Beiersdorf 1052979*Subcutaneous medprogesterone acetate for treatment of menopause and endometriosis
Pharmacia & Upjohn 1052980*Fungal sulphur source and method of using the same
Commonwealth Scientific and Industrial Research Organisation 1052981*Aminotetralins as 5-HT 1Da agonists
Eli Lilly 1051982*Use of MAO-A or MAO-B inhibitor for the treatment of vascular disorders
Thomas, Thomas 1052983*Antibacterial agents
British Biotech Pharmaceuticals 1052984*Pharmaceuticals comprising N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid for iron chelating therapy
University of Florida Research Foundation 1052985*Anti-inflammatory agents
British Biotech Pharmaceuticals 1052986*Tablets to be crunched or sucked, comprising iron as an active principle
Laboratoire Innothera 1052987*Methods and compsns for inactivating viruses
VI Technologies 1052988*Use of 2-amino-6-trifluoromethoxybenzothiazole for preventing or treating cerebellum dysfunction
Aventis Pharma 1052989*Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
Neurosearch 1052990*Use of loeramide for the treatment of microbial infections
SmithKline Beecham 1052991*Cyclic amine modulators of chemokine receptor activity
Merck 1052992*Combination of an alpha-adrenergic antagonist and a nitrogen oxide donor for treating female sexual dysfunction
Medical and Pharma Development and Investment 1052993*Use of dipeptidylpetidase inhibitors to regulate glucose metabolism
Trustees of Tufts College 1052994*Pharmaceutical compsn for nasal administration of thiocolchicoside
Sanofi-Synthelabo 1052995*Medicine for treating apoptosis dysfunction containing oligosaccharides
Laboratoires Goemar 1052996*Compsns and methods for modulating cytokine releases in response to genotoxic agents
Applied Genetic Inc Dermatics 1052998*
